AMC Health
AMC Health runs remote patient monitoring and virtual care programs for health plans, health systems, rural providers, employers, government programs including the Veterans Health Administration's Home Telehealth contract, and decentralized clinical trials. Patients get devices paired before they arrive, such as scales, blood pressure cuffs and pulse oximeters, connected through the MyCare app, a cellular tablet, a cellular modem or telephone voice prompts, and readings flow into CareConsole, its clinician platform, alongside claims, pharmacy and chart data. Machine learning models trained on outcomes of patients monitored since 2002 rank every patient daily by likelihood of deterioration, filter alerts, suggest interventions and, through an agentic layer, gather context and queue next steps within limits clinicians set. AMC's own clinicians call flagged patients the same day, prescribe and order labs, and in its top tier act as a member's primary care provider.
A peer reviewed Geisinger Health Plan study of Medicare Advantage members with heart failure found fewer admissions and readmissions, 11% lower cost and a 3.3 return on investment, and a national Medicaid plan that used AMC's risk models to select members reported 20% lower cost against matched controls. CareConsole holds FDA 510(k) clearance as a Class II remote monitoring platform, most recently K233446 in September 2024. Nesim Bildirici founded the company, legally Advanced Monitored Caregiving, Inc., in 2002, and it is based in New York.
Capability Axes
An AI Health Index grade measures what a buyer can verify from public sources on the date shown. It is not a rating of how good the product is. A vendor can build an excellent system and grade low on an axis because it publishes nothing an outsider can check. How grades read
Risk models steer a monitoring and care program that stood on its own for years before them. Models trained on outcomes since 2002 score every monitored patient daily for likelihood of deterioration, filter readings into alerts that matter, recommend interventions and, through an agentic layer, gather context and queue next steps, and they also pick which members to enroll.
The devices, connectivity options, enrollment team, licensed clinicians and primary care service carry value without any model, and the Geisinger results the company cites come from a 2008 to 2012 program. The daily ranking that decides who a nurse calls first, though, does not exist without the models.
Clinicians set the limits and can override, with the limits themselves unstated. The company says its clinical leadership sets the alert thresholds, every risk ranking comes with its reasons and any clinician can override it, and the agentic layer queues next steps only within guardrails the clinical team sets.
Flagged patients get a same day call from a clinician, who adjusts the care plan, prescribes or orders labs, and health plans choose whether their own team, AMC's clinicians or both act on what the models surface. CareConsole's clearance excludes emergency use. The thresholds, the guardrails on the agent and what happens after a missed deterioration are not set out.
Four functions are described: a risk score for likelihood of deterioration, intelligent alerting that separates real change from noise, an agentic layer that gathers context and queues next steps, and prescriptive analytics that recommends interventions.
The models are trained on two decades of home readings and outcomes, such as admissions, emergency visits and recoveries, for patients the company has monitored, joined with claims, pharmacy and chart data, and each ranking shows the reasons behind it. The November 2024 release names what they predict: emergency visits, hospitalization or death. No model type beyond machine learning, version history, update practice or prediction horizon is given.
AMC trains its own risk models on its own patients' outcomes, so no outside model provider stands behind the risk score. The agentic layer that gathers context and queues next steps is not described, so whether a language model provider receives patient data is unknown. The privacy statement names Google Analytics and otherwise refers to unnamed cloud providers, affiliates, strategic partners and service providers, all located in the United States, and no subprocessor list appears. Device makers and the cellular carriers behind the tablet and modem options also handle readings and are not named.
A 2014 study in Population Health Management by Geisinger Health Plan researchers followed Medicare Advantage members with heart failure monitored with AMC scales and voice surveys from 2008 to 2012: monthly odds of admission fell 23%, 30 and 90 day readmission odds fell 44% and 38%, cost fell 11% and return on investment was 3.3. The study is observational, comes from one plan and predates the risk models.
The company also cites a 2012 Medical Care study and a 2013 JAMA trial of home blood pressure telemonitoring. Its own retrospective study of a national Medicaid plan, 2021 to 2022, found 20% lower cost against propensity matched members. No accuracy figure for the risk models appears.
Patient data trains the models by design, and the terms around that use are general. The models learn from the outcomes of patients cared for since 2002, including admissions and emergency visits, and the privacy statement allows protected health information to be used to create deidentified data and kept as long as necessary for the stated purposes.
Whether training uses identifiable or deidentified records, whether a plan's members can be excluded and how long readings and recordings are retained are not stated. Data sits with unnamed US cloud providers, Google Analytics is the only named third party, and guardrails and how a safety event is handled are not described.
The privacy statement, modified in October 2026 and issued by Advanced Monitored Caregiving, Inc., covers the website, platform and mobile apps, explains how protected health information is collected, used, retained and disclosed, lists patients' rights to access, amend and get an accounting of disclosures, and promises breach notice within 60 days.
Nowhere does the company say it acts as a business associate to the plans and providers it serves, or as a covered entity when its clinicians treat patients directly, and no agreement or template is offered. Its cookies section names a different company, Mixtiles, an error left in the document.
The security page says AMC meets the HITRUST CSF version 9.3 risk based, two year (r2) certification criteria and that its information protection program follows NIST objectives. The certification date, scope and renewal are not given, and no report or trust portal can be opened; version 9.3 is an older release of the framework, and whether the certification has been renewed under a later one is not stated.
A leadership biography mentions an authority to operate for a Veterans Affairs telehealth program without saying it is AMC's, and encryption, penetration testing and incident response are not described.
The platform is cleared, and the risk prediction marketed as FDA cleared is not in the clearance. CareConsole holds 510(k) clearance K233446 (September 2024, Class II, product codes MWI and DXH), following K151839 and K051544, for collecting readings from home devices and questionnaires and generating notifications, alerts, reports and trend summaries for patients 12 and older, not for emergencies.
The home page advertises FDA cleared risk prediction, and a November 2024 release says this clearance lets AMC introduce machine learning models predicting emergency visits, hospitalization or death, but the FDA summary mentions no prediction, algorithm or machine learning. The security page also calls the platform registered, rather than cleared, as a Class II device.
Validation before use, monitoring for drift and checks of performance across patient groups are all promised in one passage, with clinical leadership setting thresholds and every ranking explainable. No validation results, drift reports or performance by age, sex, race, condition or connection method appear, though the program spans Medicaid, Medicare Advantage, veterans and rural patients and includes telephone users who never touch an app. The models are trained on the company's own historical patients, so whether they hold for populations unlike those it has served is the open question, and no outside audit is mentioned.
The company takes on outcomes in one model, while its terms disclaim being a provider. On the health plan page, the top tier makes AMC clinicians the primary care provider of record and states that AMC Health answers for outcomes, and in the middle tier its clinicians act alongside the member's physician. Every risk ranking can be explained and overridden by a clinician.
Against that, the terms of use, last updated December 2024, say the company is not a health care provider, provide services as is, cap liability at the amount paid for the service and have users indemnify AMC. No accuracy commitment or remedy attaches to the risk models.
Readings, claims, pharmacy data and chart history are pulled into one connected record that clinicians document in, the company says, and CareConsole's clearance describes sending data over intranet, internet, landline or mobile networks. No EHR, interface standard, marketplace listing or writing back into a plan's or provider's system is named, and how the record reaches the treating physician outside the program is not described. Readings come from third party scales, cuffs, glucose meters and oximeters, with continuous glucose monitors and wearables mentioned in the November 2024 release.
The privacy statement commits where data lives: personal information is kept in secured cloud storage provisioned by third party cloud providers in the United States, and the affiliates and service providers that maintain and process it are also located in the United States. Google Analytics data is stored on US servers. The cloud provider, region, separation between client programs and retention of readings and video visits are not stated.
Patients connect through the MyCare app, a cellular tablet, a cellular modem or telephone voice prompts, and clinicians use CareConsole on the web; no option to run inside a plan's or health system's own environment appears.
Health plans choose among three buying models with rising clinical accountability: Equip, where AMC supplies daily home data to the plan's own care team; Extend, where AMC care managers and clinicians work alongside the member's physician; and Become, where AMC clinicians serve as primary care provider of record and answer for outcomes.
No price is given, every page leads to a demo request, and nothing says whether programs are charged per enrolled patient per month, by outcome or by contract. Figures such as $676 saved per patient per month in a Medicaid heart failure study describe results, not price.
Health plans for Medicaid and Medicare Advantage, health systems, rural providers, the Veterans Health Administration and Indian Health Service, employers and clinical trial sponsors are the markets, and patients reach the service by app, cellular tablet, cellular modem or telephone voice prompts, so those without smartphones or Wi-Fi can enroll. CareConsole is cleared for patients aged 12 and older without emergency conditions.
Published results cover heart failure in Geisinger's Medicare Advantage members (Population Health Management, 2014) and in a national Medicaid plan, plus blood pressure control; other conditions and the primary care and trial settings have no results reported.
Alternatives to AMC Health
Other products that do the same kind of work as AMC Health, and what each one does.
AI enabled chronic care management for older adults, run in partnership with health systems: AI agents monitor daily vitals from connected devices in patients' homes and handle medication titration, lifestyle coaching, alert triage, care coordination and symptom assessment, working with…
Current Health gives health systems, community oncology practices and drug makers the monitoring and nursing infrastructure to deliver CAR T cell therapy, bispecific antibodies and other complex treatments outside the hospital, and to run hospital at home programs.
Huma sells a regulated platform that other organizations configure into their own clinical software, and now describes itself as an operating system for AI in regulated industries.
Impilo gives clinical teams software and device connections for operating remote care. Its patient queue organizes incoming readings, alerts, tasks and communications in one workspace.
Clinii sells care management software to physician groups, independent practices, health systems and organizations running chronic care programs.
Implicity runs a remote monitoring platform for patients with cardiac implantable electronic devices.
Pricing
Vendor-published figures are labeled as such. Figures labeled “Estimated” are derived from third-party sources and have not been confirmed by the vendor.
| Entry Price | Pricing Basis | BAA Tier | Implementation | Source |
|---|---|---|---|---|
|
Not published.
|
AMC Health prices after a demo. Health plans choose one of three models carrying rising clinical accountability: Equip, with monitoring data for the plan's own care team; Extend, with AMC care managers and clinicians alongside the member's physician; and Become, with AMC clinicians as primary care provider of record. Device kits, connectivity and enrollment outreach are part of the program, and how each is charged is not stated. | Not published. | None stated. AMC handles outreach, consent, kit delivery and setup support itself. | Vendor Published |
Savings figures such as $676 per patient per month in a Medicaid heart failure study describe outcomes, not prices.